Ginsenoside La



Compound IDCDAMM01526
Common nameGinsenoside La
IUPAC name2-[[1,2,6,6,10,17-hexamethyl-15-(2-methylprop-1-enyl)-17-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-14-oxapentacyclo[11.7.1.02,11.05,10.018,21]henicosan-7-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formulaC42H70O13

Experimental data

Retention time15.06
Adduct[M+K]+
Actual mz821.451
Theoretical mz821.445
Error7.23
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.307

Identifiers and class information

Inchi keyHXXZFHABSSZFHB-UHFFFAOYNA-N
SmilesOCC1OC(OC2CCC3(C)C(CCC4(C)C3CC5OC(C=C(C)C)CC(OC6OC(CO)C(O)C(O)C6O)(C)C7CCC4(C)C57)C2(C)C)C(O)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)12
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)783.007
Computed dipole moment(dipole)8.514
Total solvent accessible surface area (SASA)1078.05
Hydrophobic component of SASA (FOSA)781.484
Hydrophilic component of SASA (FISA)290.928
Pie component of the SASA (PISA)5.641
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2227.98
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)21.15
Free energy of solvation of dipole (dip^2/V)0.0325323
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0554901
Globularity descriptor (glob)0.765242
Predicted polarizability in cubic angstroms (QPpolrz)73.432
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.644
Predicted octanol/gas partition coefficient (QPlogPoct)48.6
Predicted water/gas partition coefficient (QPlogPw)33.571
Predicted octanol/water partition coefficient (QPlogPo/w)1.586
Predicted aqueous solubility (QPlogS)-5.464
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.912
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.358
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)17.26
Predicted brain/blood partition coefficient (QPlogBB)-3.653
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)6.149
Predicted skin permeability, log Kp (QPlogKp)-5.421
PM3 calculated ionization potential (IP(ev))9.659
PM3 calculated electron affinity (EA(eV))-0.887
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-0.28
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)19.496
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)200.558
Number of nitrogen and oxygen atoms (#NandO)13
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2

Copyright © 2025